Castuner

ASCO Guidelines

American Society of Clinical Oncology (ASCO)

ASCO Guidelines Podcast breaks down pivotal recommendations from the latest evidence-based clinical practice guidance and provides insight into daily patient care. Listen to stay up to date with the ever-evolving landscape of cancer research and treatment.

Poddens webbplats

Lyssna i din app

Avsnitt

203 avsnitt

  1. Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline 2026.1.0 14:19
  2. Breast Cancer Follow-Up and Surveillance After Primary Treatment Guideline Update 19:32
  3. Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline 2026.1.0 21:26
  4. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2 9:00
  5. Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1 17:45
  6. Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline 17:31
  7. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2 19:00
  8. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1 13:27
  9. Systemic Treatment of Thyroid Cancer Guideline 23:25
  10. Patient-Clinician Communication Guideline Update 31:22
  11. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update 28:55
  12. White Blood Cell Growth Factors Guideline Update 23:22
  13. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2 19:36
  14. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1 18:03
  15. Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1 13:37
  16. Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline 22:18
  17. Management of Cancer During Pregnancy Guideline 34:50
  18. Management of Antineoplastic Extravasation: ONS-ASCO Guideline 13:28
  19. Postmastectomy Radiation Therapy: ASTRO-ASCO-SSO Guideline 15:38
  20. Geriatric Assessment Global Guideline 16:19
  21. Oncology Medical Homes: ASCO-COA Standards Update 16:11
  22. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2025.1 Part 2 15:16
  23. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2025.1 Part 1 11:30
  24. Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards Update 25:05
  25. Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Guideline 19:20
  26. Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Guideline Update 22:48
  27. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Rapid Update 9:22
  28. Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update 20:51
  29. Fertility Preservation in People with Cancer Guideline Update 32:09
  30. Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline 20:19
  31. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2024.3 Part 1 10:48
  32. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2 15:20
  33. TORS in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma Guideline 22:28
  34. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update 19:04
  35. Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline 16:25
  36. Treatment of Pleural Mesothelioma Update 10:37
  37. Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline 16:14
  38. Systemic Therapy for SCLC Rapid Update 14:28
  39. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2 9:53
  40. Management of Locally Advanced Rectal Cancer Guideline 12:23
  41. Management of Stage III NSCLC Rapid Update 8:02
  42. Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline 17:44
  43. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1 12:24
  44. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards 17:52
  45. Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update 11:23
  46. Management of Fatigue in Adult Survivors of Cancer: ASCO-SIO Guideline Update 19:24
  47. Palliative Care for Patients with Cancer Guideline Update 20:30
  48. Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy: ISOO-MASCC-ASCO Guideline 20:10
  49. Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations 21:39
  50. Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update 15:28